Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,047,251Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1NanoAlvand

02 1Naprod Life Sciences

03 2Acrotech Biopharma

04 4Mundipharma

05 1Servier Canada

06 2Teva Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Pralatrexate

Brand Name : Pralym

Dosage Form : Vial

Dosage Strength : 20MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Pralatrexate

Brand Name :

Dosage Form : Liquid Injection

Dosage Strength : 20MG/ML

Packaging : 1 ml and 2 ml pack

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PRALATREXATE

Brand Name : FOLOTYN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 20MG/ML (20MG/ML)

Packaging :

Approval Date : 2009-09-24

Application Number : 22468

Regulatory Info : RX

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PRALATREXATE

Brand Name : FOLOTYN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 40MG/2ML (20MG/ML)

Packaging :

Approval Date : 2009-09-24

Application Number : 22468

Regulatory Info : RX

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

pralatrexate

Brand Name : Folotyn

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

pralatrexate

Brand Name : Folotyn

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

pralatrexate

Brand Name : Folotyn

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

pralatrexate

Brand Name : Folotyn

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PRALATREXATE

Brand Name : FOLOTYN

Dosage Form : SOLUTION

Dosage Strength : 20MG/ML

Packaging : 1ML VIAL

Approval Date :

Application Number : 2481820

Regulatory Info : Prescription

Registration Country : Canada

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PRALATREXATE

Brand Name : PRALATREXATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 20MG/1ML

Packaging :

Approval Date :

Application Number : 206167

Regulatory Info :

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PRALATREXATE

Brand Name : PRALATREXATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 40MG/2ML

Packaging :

Approval Date :

Application Number : 206167

Regulatory Info :

Registration Country : USA

blank